在芯片上的球形模型上对光动力疗法的治疗输出进行计算建模
Hossein Kazempour1, Fatemeh Teymouri1, Maryam Khatami2
1Chemical and Petroleum Engineering Department, Sharif University of Technology, Tehran, Iran.
Journal of photochemistry and photobiology. B, Biology
|July 11, 2024
概括
这项研究模拟了微流体系统中的光动力学疗法 (PDT),揭示了氧气和光敏剂 (PS) 的分布对癌细胞死亡产生了重大影响. 优化药物轻度间隔和PS选择可以提高治疗疗效.
科学领域:
- 生物医学工程 生物医学工程
- 光动力疗法研究研究 光动力疗法研究
- 在瘤学中的微流体学.
背景情况:
- 光动力疗法 (PDT) 使用光,光敏剂和氧气来产生用于癌症治疗的细胞毒性化合物.
- 微流体系统为分析光敏化剂 (PSs) 提供体内环境模拟.
- 以前的PDT研究往往忽视了液体流对氧气和PS度的影响,限制了结果的可靠性.
研究的目的:
- 在微流体系统和多细胞球体中配合氧气和PS运输.
- 调查氧气和PS度概况及其与PDT诱导的细胞死亡的相关性.
- 分析药物-光间隔 (DLI),流动率,PS类型,微通道高度和流速对治疗结果的影响.
主要方法:
- 在微流体通道和球体体内开发了氧气和PS的合运输模型.
- 在多细胞球体体内模拟PDT诱导的细胞死亡进展.
- 参数学研究了DLI,流动率,PS组成,微通道高度和入口流量率的影响.
主要成果:
- PDT诱导的细胞死亡始于球形表面,并向内进化,与实验观测一致.
- 足够的5小时的DLI确保了统一的PS分配.
- 不同的PS组合 (ALA-PpIX与mTHPC/Photofrin) 呈现出不同的氧气消耗率和细胞死亡动力学;高于189mW/cm2的流动率显示出回报率下降,微通道尺寸/流速呈现出复杂的权衡.
结论:
- 对氧气和PS运输的准确建模对于微流体系统中可靠的PDT模拟至关重要.
- 优化DLI和选择适当的PS是有效PDT的关键,平衡细胞死亡诱导与氧气可用性.
- 微流体设计参数,如通道高度和流量,需要仔细考虑,以管理氧气供应和PS度,以获得最大的治疗效果.
更多相关视频
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
2.3K
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.6K
相关概念视频
Power Expended by a Constant Force
The relationship between work done and the time taken to do it can be explained using the concept of power. For example, several sprinters in a race may have the same velocity when they reach the finish line, therefore doing the same amount of work, but the winner does it in the least amount of time. Thus, power is defined as the rate of doing work. Since work can vary as a function of time, the average power is defined as the work done during a time interval, divided by the time interval.
Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
